FBTAX holdings — Fidelity Advisor Biotechnology Fund
Fidelity Advisor Biotechnology Fund (FBTAX) held 129 positions with net assets of $2.20B as of July 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 46.9% of the fund, led by ABBV, GILD, SYRE.
FBTAX top holdings
- ABBV ABBVIE INC — 14.71% ($324M)
- GILD GILEAD SCIENCES INC — 5.70% ($125M)
- SYRE SPYRE THERAPEUTICS INC — 3.83% ($84.3M)
- ALNY ALNYLAM PHARMACEUTICALS INC — 3.62% ($79.6M)
- DNTH DIANTHUS THERAPEUTICS INC — 3.55% ($78.1M)
- COGT COGENT BIOSCIENCES INC — 3.25% ($71.4M)
- ORKA ORUKA THERAPEUTICS INC — 3.24% ($71.2M)
- INSM INSMED INC — 3.05% ($67.1M)
- RVMD REVOLUTION MEDICINES INC — 3.00% ($66.0M)
- ARGX ARGENX SE — 3.00% ($65.9M)
- ASCENDIS PHARMA A/S — 2.99% ($65.7M)
- BIIB BIOGEN INC — 2.71% ($59.7M)
- MBX MBX BIOSCIENCES INC — 2.45% ($53.9M)
- AMGN AMGEN INC — 2.37% ($52.0M)
- AMLX AMYLYX PHARMACEUTICALS INC — 2.25% ($49.4M)
- PCVX VAXCYTE INC — 1.97% ($43.3M)
- Fidelity Revere Street Trust — 1.96% ($43.2M)
- MRNA MODERNA INC — 1.60% ($35.1M)
- RLAY RELAY THERAPEUTICS INC — 1.58% ($34.8M)
- VRDN VIRIDIAN THERAPEUTICS INC — 1.53% ($33.7M)
- NTRA NATERA INC — 1.43% ($31.4M)
- KINIKSA PHARMACEUTICALS INTERNATIONAL PLC — 1.41% ($31.0M)
- VRTX VERTEX PHARMACEUTICALS INC — 1.39% ($30.5M)
- ELVN ENLIVEN THERAPEUTICS INC — 1.25% ($27.5M)
- ALMS ALUMIS INC — 1.22% ($26.7M)
What are FBTAX's top 10 holdings?
ABBV (14.7%), GILD (5.7%), SYRE (3.8%), ALNY (3.6%), DNTH (3.5%), COGT (3.2%), ORKA (3.2%), INSM (3.0%), RVMD (3.0%), ARGX (3.0%).
How many stocks are in FBTAX?
Fidelity Advisor Biotechnology Fund reported 129 holdings as of July 31, 2026.
Share classes: FBTAX, FBTCX, FBTIX, FBTTX, FIJYX